Reshmi Parameswaran received her Master’s degree in Biochemistry from Mahatma Gandhi University, India. She moved to Israel for her Ph.D. studies and obtained a Ph.D. degree in Cell Biology from the Weizmann Institute of Science, Israel in 2006. She studied B cell development and developed cell therapy approaches for B cell malignancies using mesenchymal cells over-expressing Activin A. She did her post-doctoral fellowship at Children’s Hospital Los Angeles, where she explored the role of B cell activating factor (BAFF) in pediatric acute lymphoblastic leukemia (ALL) and she was the first to identify the expression of BAFF receptors on ALL cells.

Dr. Parameswaran joined as a tenure track faculty in the Department of Medicine, Case Western Reserve University in October 2016. Her lab focuses on developing cell therapy methods for treating various hematological malignancies using Natural Killer (NK) cells, CAR-T cells and CAR-NK cells.